Skip to main content
. 2019 Jun 28;6:243–257. doi: 10.1016/j.ejro.2019.06.005

Fig. 1.

Fig. 1

A 62 year old acutely encephalopathic female with acute toxic leukoencephalopathy (ATL), who had been administered fludarabine 3 weeks prior to imaging for treatment of multiple myeloma. She expired 19 days after MRI. 1A-C: there was bilateral, symmetric PVWM hyperintensity (arrows) on FLAIR (A), with reduced diffusion on DWI (B) and on ADC map (C).